Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 8 Mar 22 253G2 Offering circular supplement
- 17 Feb 22 253G2 Offering circular supplement
- 10 Jan 22 253G2 Offering circular supplement
- 3 Jan 22 253G2 Offering circular supplement
- 14 Dec 21 253G2 Offering circular supplement
- 14 Dec 21 253G2 Offering circular supplement
- 14 Dec 21 253G3 Offering circular supplement
-
14 Dec 21 QUALIF Notice of qualification
- 1 Dec 21 1-A/A Offering $7.5M in Equity
- 12 Oct 21 1-A/A Offering $7.5M in Equity
- 9 Aug 21 1-A Offering $7.5M in Equity
Filing view
External links
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Qualification | |
Date Qualified: | December 13, 2021 4:00 P.M. |
Form: | 1-A |
CIK: | 0000849636 |
Company Name: | RespireRx Pharmaceuticals Inc. |
File Number: | 024-11602 |